RecruitingNCT04467333

Giessen Pulmonary Hypertension in Lung Cancer Registry

Sponsor

University of Giessen

Enrollment

500 participants

Start Date

Jun 29, 2020

Study Type

OBSERVATIONAL

Conditions

Pulmonary Hypertension Due to Lung Diseases and Hypoxia

Summary

The aim of this study is to investigate the frequency and implications of pulmonary hypertension in lung cancer patients. To do so, data will be collected from all lung cancer patients at the university hospital Giessen. All data will be analyzed for possible hints of pulmonary hypertension as a comorbidity in lung cancer patients. All information will be generated from the regular guidelines based course of treatment and there will be no interventions. This study will serve as a prospective register for all lung cancer patients treated at the university hospital Giessen.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This registry study is collecting data on patients with lung cancer who are also diagnosed with pulmonary hypertension (high blood pressure in the arteries of the lungs). Because pulmonary hypertension is an underrecognized complication in lung cancer, this registry aims to learn more about how common it is and how it affects outcomes. **You may be eligible if:** - You have lung cancer and are being treated or followed at the University of Giessen Lung Cancer Center in Germany **You may NOT be eligible if:** - There are no specific exclusion criteria listed for this registry Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.